People

Yehezkel Ben-Ari

Yehezkel Ben-Ari, PhD

President, Acting Chief Executive Officer and Co-founder

Read Dr. Ben-Ari’s blog



Denis Ravel

Denis Ravel, PhD

Chief Pharmaceutical Development Officer and Co-founder



Diana Ferrari

Diana Ferrari, PhD

Researcher and Project Manager



Magali Conesa, PhD

Magali Conesa, PhD

Researcher and Administrative Manager



Natalia Lozovaya

Natalia Lozovaya, PhD

Senior Researcher responsible for research of new therapeutic indications for Bumetanide



Robin Cloarec

Robin Cloarec, PhD

Post-doctoral Researcher



Amandine Dufour

Amandine Dufour, PhD

Post-doctoral Researcher



Séverine Platel

Séverine Platel, PhD

Post-doctoral Researcher



Baptiste Riffault

Baptiste Riffault, PhD

Post-doctoral Researcher



Morgane Chiesa

Morgane Chiesa

PhD Student



Amandine Fernandez

Amandine Fernandez

PhD Student



Elise Gauthier

Elise Gauthier

Communication Officer



Thi-Thien Bui

Thi-Thien Bui

Assistant Engineer



Nadia Oumar

Nadia Oumar

Assistant Engineer



Rahima Ahamada

Rahima Ahamada

Technician



Maxime Billon-Grand

Maxime Billon-Grand

Technician




Yehezkel Ben-Ari

Yehezkel Ben-Ari, PhD

President, Acting Chief executive Officer and Co-founder

Physiologist and biophysicist, Yehezkel Ben-Ari (YBA) has made many seminal discoveries on brain developmental sequences, infantile and adult epilepsies, the mechanisms of migration disorders and anoxic insults etc. These include the excitatory /inhibitory shift of GABA actions during brain development, the excitatory actions of GABA in epilepsies and other brain disorders, the formation of aberrant synapses in the epileptic brain, the maturation of neuronal and network activities and associated sequences. Author of 500 publications and amongst the highest quoted neuroscientists, Yehezkel Ben-Ari has received many prizes including the US and European Epilepsy research highest prizes and the INSERM 2009 Biomedical prize for his contributions to brain development. He has directed an INSERM unit for over 20 years, founded INMED and directed it since its foundation until September 2011.
Yehezkel Ben-Ari has recently suggested two major concepts including the “check point“ and “Neuroarcheology” concepts that suggest that neuronal activity controls the correct implementation of developmental sequences and a failed implementation of the program leads to delayed maturation of electrical properties of misplaced and misconnected neurons that in an adult brain will conserve immature features. This paves the way to novel therapeutic strategies based on the use of agents that specifically block immature channels and transporters. This strategy has been used successfully with our diuretic approach to treat ASD and epilepsies.



Eric Lemonnier

Eric Lemonnier, MD, PhD

Co-founder

Eric Lemonnier is a child and adolescent psychiatrist at the University Hospital in Brest, and is the head of the Research Center for Autism of Brittany. Dr. Lemonnier earned his Ph.D. in Paris in 1993 with the silver medal of the University of Port Royal, Paris, as well as his DEA in neuroscience. Before the opening of the Research Center for Autism of Brittany, to which he contributed to its creation, Dr. Lemmonier worked first as a psychiatrist at La Pitié-Salpêtrière in Paris, and then as a general child and adolescent psychiatrist at the University Hospital in Brest. Dr. Lemonnier created a national newspaper for doctors and doctors to be “Internes et chefs”.
Dr. Lemonnier has authored numerous publications in books and scientific journals, and has co-authored a patent with Dr. Y. Ben-Ari.



Nouchine Hadjikhani

Nouchine Hadjikhani, MD, PhD

Co-founder

Dr. Hadjikhani is an Associate Professor in Radiology at Harvard Medical School, and has more than 15 years of experience in brain imaging, with more than 50 publications in peer-reviewed journals.
She graduated from Medical School in Lausanne, Switzerland in 1992, and pursued her post-doctoral career at the Karolinska Institute in Sweden and then at the Martinos Center for Biomedical Imaging in Boston. She has been doing research on autism since 2000, using brain imaging and other behavioral measures such as eye-tracking. In 2006, she was the recipient of a Swiss National Science Foundation Professorship.



Dennis W. Choi

Dennis W. Choi, MD, PhD

Title

Dr. Dennis W. Choi



Andy Gyenes

Andy Gyenes, MS

Title

Andy Gyenes




› Pasko Rakic


Duberg Professor of Neurobiology and Neurology
Chairman, Department of Neurobiology, Yale University
Director, Kavli Institute of Neuroscience, Yale University

› David Amaral


Distinguished Professor
Department of Psychiatry and Behavioral Sciences
Director of Research, UC Davis MIND Institute

› Catherine Barthelemy, MD


Professeur des Universites, Praticien hospitalier
Universite Francois-Rabelais, Tours, France

› Rutger J. van der Gaag, MD


University Medical Centre Nijmegen St. Radboud, Department of Psychiatry, Nijmegen
University Centre for Child and Adolescent Psychiatry, Nijmegen, The Netherlands

› Patrick Bolton, MD


Professor of Child and Adolescent Psychiatry
King’s College London, University of London



Yehezkel Ben-Ari

Yehezkel Ben-Ari, PhD

President, Acting Chief Executive Officer and Co-founder

Physiologist and biophysicist, Yehezkel Ben-Ari (YBA) has made many seminal discoveries on brain developmental sequences, infantile and adult epilepsies, the mechanisms of migration disorders and anoxic insults etc. These include the excitatory /inhibitory shift of GABA actions during brain development, the excitatory actions of GABA in epilepsies and other brain disorders, the formation of aberrant synapses in the epileptic brain, the maturation of neuronal and network activities and associated sequences. Author of 500 publications and amongst the highest quoted neuroscientists, Yehezkel Ben-Ari has received many prizes including the US and European Epilepsy research highest prizes and the INSERM 2009 Biomedical prize for his contributions to brain development. He has directed an INSERM unit for over 20 years, founded INMED and directed it since its foundation until September 2011.
Yehezkel Ben-Ari has recently suggested two major concepts including the “check point“ and “Neuroarcheology” concepts that suggest that neuronal activity controls the correct implementation of developmental sequences and a failed implementation of the program leads to delayed maturation of electrical properties of misplaced and misconnected neurons that in an adult brain will conserve immature features. This paves the way to novel therapeutic strategies based on the use of agents that specifically block immature channels and transporters. This strategy has been used successfully with our diuretic approach to treat ASD and epilepsies.


Eric Lemonnier

› Eric Lemonnier, MD, PhD

Co-founder

Eric Lemonnier is a child and adolescent psychiatrist at the University Hospital in Brest, and is the head of the Research Center for Autism of Brittany. Dr. Lemonnier earned his Ph.D. in Paris in 1993 with the silver medal of the University of Port Royal, Paris, as well as his DEA in neuroscience. Before the opening of the Research Center for Autism of Brittany, to which he contributed to its creation, Dr. Lemmonier worked first as a psychiatrist at La Pitié-Salpêtrière in Paris, and then as a general child and adolescent psychiatrist at the University Hospital in Brest. Dr. Lemonnier created a national newspaper for doctors and doctors to be “Internes et chefs”.
Dr. Lemonnier has authored numerous publications in books and scientific journals, and has co-authored a patent with Dr. Y. Ben-Ari.


Nouchine Hadjikhani

› Nouchine Hadjikhani, MD, PhD

Co-founder

Dr. Hadjikhani is an Associate Professor in Radiology at Harvard Medical School, and has more than 15 years of experience in brain imaging, with more than 50 publications in peer-reviewed journals.
She graduated from Medical School in Lausanne, Switzerland in 1992, and pursued her post-doctoral career at the Karolinska Institute in Sweden and then at the Martinos Center for Biomedical Imaging in Boston. She has been doing research on autism since 2000, using brain imaging and other behavioral measures such as eye-tracking. In 2006, she was the recipient of a Swiss National Science Foundation Professorship.